• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Cold Chain Packaging and Logistics

    How Artificial Intelligence and Machine Learning are Transforming the Life Sciences

    Challenges of Preparing Highly Potent Oral Products

    Bioprocessing Trends

    Sustainable Manufacturing
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    groninger Continues Growth in the US

    Catalent Bolsters Cell and Gene Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    What Does the Future of API Synthesis Look Like?

    Pasithea Signs CMC Development and Manufacturing Agreement

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Jaguar Health Achieves Key Milestone for Crofelemer API Manufacturer
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Bolsters Cell and Gene Services

    CDMO Sirio Pharma Completes the Acquisition of Best Formulations

    Meeting the Container Closure Integrity Requirements in the Revised EU Annex 1

    Case Study: Secondary Sourcing Strategies to Ensure Supply Chain Security

    Beat the Supply Chain Backlog
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Experic Expands Analytical Capabilities and Facilities

    List Labs Expands Manufacturing Capacity

    Catalent Bolsters Cell and Gene Services

    Crown Bioscience to Acquire Indivumed’s Service Biz and Supporting Biobank

    Stevanato Group, Transcoject Partner on Pre-Fillable Syringe Polymer Options
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Adare Partners with Veeva to Strengthen Quality Operations

    KBI Secures Swissmedic Regulatory Establishment License for Facility in Geneva

    Enhancing Ease of Use, Batch Turnaround, and Process Flexibility

    Understanding the Essential Role of a Qualified Person

    Altasciences Los Angeles Clinical Site Receives CAP Accreditation
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Syngene International Ltd.

    BioIVT

    Bachem

    Quotient Sciences

    Societal CDMO
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Syngene International Ltd.

    BioIVT

    Bachem

    Quotient Sciences

    Societal CDMO
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Biomanufacturing Trends and Outlook 2017: Where Is It All Going?

    A look at the technological advances permeating (bio)pharma manufacturing

    Related CONTENT
    • COVID Booster Vaccines: What’s Next for FDA
    • The Future of Clinical Trials
    • Let’s Get Genuine
    • Maintaining Critical Drug Supply During COVID-19
    • Global Outsourcing Trends
    Ben Locwin, Contributing Editor04.20.17
    Compared with just two years ago, biomanufacturing continues to advance and evolve. For example, according to BioPlan Associates’ 2015 annual report, more than 90% of facilities were using single use/disposable technologies, and planning and future modeling was designed to balance out the various costs and risks associated with disposable vs. stainless steel technologies for the long term.

    Is technology the end-all?
    Currently, more than 9 out of 10 contract manufacturing organizations (CMOs) are using disposables, and they are continuing to see benefits, though they are also reporting some dissatisfaction with the offerings and future trajectory of the disposables market.

    Oftentimes, technology is erroneously considered a proxy for the hard work and activities in the industry. It’s easy to point to something like wearable tech, social media platforms, single-use disposables and hold that as a mental heuristic for the cause of pharma industry improvements. But as the saying goes, “The map is not the territory,” and just because process improvements are happening concurrently and coincidentally with the use of disposables and other technology, doesn’t mean that those are the key drivers of that improvement.

    Most organizations continue to report that they are making improvements to their processes and practices internally and methodologically. Lean and Six Sigma process improvement practices continue to be adopted, refined, and pushed through organizations, which leads to greater scrutiny of all business practices, and opportunities to change how work is approached. But because internal practices and methodologies aren’t measurable industry-wide in the same way that total units sold of single-use technologies are, these work practice evolutions tend to be minimized and under-reported, when in reality are the unsung heroes of industry improvement.

    Increasing confidence in analytical testing continues in the industry, and the thinking tends to go that better analytics and higher-precision analytical results leads to better performance, which isn’t necessarily true. In the last two years, however, there has been extraordinarily more focus and work on biosimilars in the industry. The current analytical requirements for biosimilars are generally not stringent enough, and according to many industry experts, perhaps not similar enough to the trial rigor required of the innovator drug to make biosimilars an area of continued large-scale refinement.

    Biotherapeutic developers and CDMOs are tending to see better results than CMOs by refinements in how cell cultures are optimized, and how developability is approached in ways that can harness advancements in risk assessments to increase the likelihood of performance of candidate molecules.

    Technology in pharma and biomanufacturing
    Gartner’s Symposium in Quarter 4, 2016 identified a number of technological platform advances that will in some form permeate many business models, and pharmaceutical manufacturing is no different.

    AI and machine learning. Artificial intelligence (AI) and machine learning involve various levels of deep learning, neural networks, natural language processing (NLP—not to be confused with neurolinguistics programming), and other non-algorithmic-based rule systems. I have used a few of these systems being piloted for clinical trials to help refine designs of trials and ‘learn’ from real-time trial data.

    Intelligent apps. Clearly, there are benefits to apps, which remind patients to, for example, take their medications, or adhere to some other healthcare treatment protocol. But apps that can ‘learn’ continually from ever-changing input data can provide context and suggestions to users when used for more complex applications, such as in the clinical trials oversight as mentioned above.

    Virtual and augmented reality for pharma. Using virtual reality (VR), or augmented reality, for medical training is something that is just beginning to occur in a compelling way. I have used some of these technologies firsthand, and their ability to impact how training and understanding of complex things occurs, is monumental. The major drawback here is that it’s a ‘worst practice’ to simply take content that would have been taught in a lecture or online and force it into three dimensions of VR. Just as there is a ‘right’ modality for certain training applications, VR and AR are particularly suited for complex visuals where 3-D manipulation can help deeper understanding.

    Digital twin. If this is the first place and time you’re hearing of this term and technology, I can guarantee that it won’t be the last! A digital twin is a dynamic model of a physical system that uses data collected by sensors to interpret a sense of its state, develop responses to environmental changes, and improve operations. Top-level digital twins have input from three major sources: metadata of classification and composition; data about current status (temperature, spatial location, time series, mass, velocity); and onboard analytics to develop responses (algorithms and adaptive learning rules for various input levels). Preventive maintenance and instrument/equipment status can be predicted and ‘operationanability maxima’ can be achieved (i.e., as in a design-of-experiments view, there are certain operating ‘maxima’ that give the best possible outputs given a series of inputs).

    Conversational systems. Imagine optical character recognition (OCR) on steroids. OCR is a machine system, which can ‘read’ text, say in printed form, and use it to fill out fields and record data. Conversational systems use ambient meshes to ‘listen’ to discussions and dialogs, and then build machine learning from it. Being able to access cloud or stored data can also allow the conversational system to build sorts-of ‘mind maps’ with hyperlinked data and programs/apps that would link together complex chains of reasoning.

    Mesh app, service architecture, and adaptive security. Unless you’re an expert in IT and security technology, you may have just had your eyes glazed over. But there are some very innovative features here. A mesh app would take many back-end services of a company or organization and link them together—desktop, telephone, smart devices, internal personnel measurement systems, biomanufacturing distributed control systems (DCS), and any other services. It would all be scalable and allow a continuous experience for each user in one place. Of course, the latter part of this section’s title refers to the fact that these deep linkages present huge challenges for digital security. Continuous monitoring of user behavior and system behavior has been deemed a requirement of good security, but also poses Big Brother privacy concerns for most users. This is the antecedent to good platforms and security measures in the Internet of Things (IoT).

    Conclusion
    So the major themes above can be grouped into ‘intelligence everywhere,’ ‘intertwining of the digital and the real,’ and the ‘mesh of platforms.’

    Of course, there’s a tenet in pharma biomanufacturing that the industry lags other high-tech industries by about 20 years. Oftentimes, the reason most cited is that pharma manufacturing is shackled because of regulatory compliance requirements (FDA, EMA, MHRA, etc.), but many of the other competitively advanced industries—aerospace, food and beverage, automotive—are similarly regulated and in some cases to a higher degree.

    What is clear is that we will continue to see an industry in flux, and how we approach biomanufacturing as an industry will depend on many factors, not the least of which includes a new presidential cabinet in the U.S., pressures to reduce drug prices, drug pricing negotiation rules applied between pharma and payers, and a new commissioner at FDA. 

    References
    • BioPlan Associates. (2015). Twelfth annual report and survey of biopharmaceutical manufacturing capacity and production.
    • Zurdo, J., Arnell, A., Obrezanova, O., Smith, N., Gallagher, T., de la Cuesta, R., Locwin, B. (2015). Developability assessment workflows to de-risk biopharmaceutical development. in Kumar, S., & Kumar Singh, S. (eds.). Developability of biotherapeutics: Computational approaches. CRC Press.

    Ben Locwin
    Contributing Editor

    Ben Locwin, PhD, MBA, MS, is a contributing editor to Contract Pharma and the president of Healthcare Science Advisors. He is an expert contact for the American Association of Pharmaceutical Scientists (AAPS), a committee member of the American Statistical Association (ASA), and has been featured by the CDC, the Associated Press, The Wall Street Journal, Forbes, and other media outlets. Follow him at @BenLocwin.
    Related Searches
    • contract pharma
    • capacity
    • Biomanufacturing
    • training
    Suggested For You
    COVID Booster Vaccines: What’s Next for FDA COVID Booster Vaccines: What’s Next for FDA
    The Future of Clinical Trials The Future of Clinical Trials
    Let’s Get Genuine Let’s Get Genuine
    Maintaining Critical Drug Supply During COVID-19 Maintaining Critical Drug Supply During COVID-19
    Global Outsourcing Trends Global Outsourcing Trends
    Clinical Trials are Transforming Right Before Our Eyes Clinical Trials are Transforming Right Before Our Eyes
    Modularity in Injectables Manufacturing Modularity in Injectables Manufacturing
    Astellas, LabCentral Partner to Help Emerging Biotechs Accelerate Research Astellas, LabCentral Partner to Help Emerging Biotechs Accelerate Research
    Fortifying Logistics with Technology for Decentralized Trials Fortifying Logistics with Technology for Decentralized Trials
    A Look Into COVID Vaccines, Development and Outsourcing A Look Into COVID Vaccines, Development and Outsourcing
    The Real Cost of Bringing Manufacturing Home The Real Cost of Bringing Manufacturing Home
    Veklury Drives 2Q Growth for Gilead Veklury Drives 2Q Growth for Gilead
    AbbVie AbbVie's 2Q Revenue up 34%
    BMS 2Q Revenues up 16% BMS 2Q Revenues up 16%
    Action Trumps Fear Action Trumps Fear

    Related Online Exclusives

    • Biologics, Proteins, Vaccines
      COVID Booster Vaccines: What’s Next for FDA

      COVID Booster Vaccines: What’s Next for FDA

      FDA Atty comments on the ongoing vaccine rollout what we can expect for other COVID vaccines in development going forward.
      09.13.21

    • Clinical Trials
      The Future of Clinical Trials

      The Future of Clinical Trials

      Dr. Greg Licholai of ICON plc on key market trends, the future of clinical trials and the acquisition of PRA.
      Kristin Brooks, Managing Editor 09.09.21

    • Let’s Get Genuine

      Let’s Get Genuine

      LinkedIn sales pitches are going away in favor of being real.
      David G. Jensen, Contributing Editor 09.09.21


    • Logistics | Supply Chain
      Maintaining Critical Drug Supply During COVID-19

      Maintaining Critical Drug Supply During COVID-19

      Vincent Colicchio from Dr. Reddy’s talks about the challenges and solutions of maintaining supply during the pandemic.
      Tim Wright, Editor, Contract Pharma 09.09.21

    • Global Outsourcing Trends

      Global Outsourcing Trends

      Lonza’s Jan Vertommen talks about building global manufacturing and development networks to advance innovative, life-saving therapies.
      Tim Wright, Editor, Contract Pharma 09.09.21

    Loading, Please Wait..
    Trending
    • Sarepta And Catalent Expand Manufacturing Partnership
    • Forge Biologics Strengthens Genetic Medicine CDMO Capabilities
    • Colorcon Signs Agreement To Purchase Airnov Healthcare Packaging
    • The Ongoing Evolution And Implementation Of DCTs In 2023
    • EyePoint Pharmaceuticals To Build GMP Mfg. Facility In Northbridge, MA
    Breaking News
    • Pasithea Signs CMC Development and Manufacturing Agreement
    • Experic Expands Analytical Capabilities and Facilities
    • List Labs Expands Manufacturing Capacity
    • groninger Continues Growth in the US
    • Catalent Bolsters Cell and Gene Services
    View Breaking News >
    CURRENT ISSUE

    November/December 2022

    • Cold Chain Packaging and Logistics
    • Optimizing Supply Chains for Allogeneic Cell Therapy Trials
    • Sustainable Manufacturing
    • Bioprocessing Trends
    • How Artificial Intelligence and Machine Learning are Transforming the Life Sciences
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login